Thursday, October 20th |
| 7:00 - 7:30 |
Continental Breakfast |
|
| 7:30 - 7:35 |
Welcome & Opening Remarks
Emmett Cunningham, Jr., MD, PhD, MPH, Partner – Clarus Ventures, LLC
|
|
| 7:35-7:50 |
Opening Remarks
Gilbert Kliman, MD, Managing Director – InterWest Partners
Emmett Cunningham, Jr., MD, PhD, MPH, Partner – Clarus Ventures, LLC
William Link, PhD, Managing Director – Versant Ventures |
|
| 7:50-9:20 |
Private Biotech/Pharma Company Showcase
Co-Moderators:
Schalon Newton, VP, Strategic Marketing & Business Development - Santen, Inc.
Calvin W. Roberts, M.D., Corporate VP and Chief Medical Officer - Bausch & Lomb
| 7:50-7:58 |
Eleven Biotherapeutics |
Abbie Celniker, CEO |
| 7:58-8:06 |
EyeGate Pharmaceuticals |
Stephen From, CEO |
| 8:06-8:14 |
Aerie Pharmaceuticals |
Thomas van Haarlem, CEO |
| 8:14-8:22 |
Inotek Pharmaceutical Corporation |
Paul Howes, CEO |
| 8:22-8:30 |
Mimetogen Pharmaceuticals |
Garth Cumberlidge, President & CEO |
| 8:30-8:38 |
Promedior, Inc. |
Nick Colangelo, President & CEO |
| 8:38-8:46 |
Alimera Sciences |
Dan Myers, President & CEO |
| 8:46-8:54 |
iCo Therapeutics |
Andrew Rae, CEO |
| 8:54-9:02 |
Neurotech |
Ted Danse, President & CEO |
| 9:02-9:10 |
MacuCLEAR, Inc. |
Philip Ralston, President & CEO |
| 9:10-9:18 |
EOS Neuroscience |
Ben Matteo, CEO |
|
|
| 9:20-9:50 |
Morning Refreshment & Networking Break
|
|
| 9:50 - 11:20 |
Private Device Company Showcase
Co-Moderators:
Robin Bellas, Partner - Morgenthaler Ventures
K. Angela Macfarlene, President & CEO - ForSight Labs LLC
| 9:50-9:58 |
Ocular Therapeutix, Inc. |
Amar Sawhney, President & CEO |
| 9:58-10:06 |
Avedro, Inc. |
David F. Muller, CEO |
| 10:06-10:14 |
AcuFocus, Inc. |
Ed Peterson, CEO |
| 10:14-10:22 |
ReVision Optics |
John T. Kilcoyne, President & CEO |
| 10:22-10:30 |
PowerVision |
Barry Cheskin, Co-Founder, President & CEO |
| 10:30-10:38 |
AkkoLens International BV |
Michiel Rombach, MD, CEO |
| 10:38-10:46 |
WaveTec Vision Systems |
Tom Frinzi, President & CEO |
| 10:46-10:54 |
Implandata Ophthalmic Products |
Max Georg Ostermeier, CEO |
| 10:54-11:04 |
Sensimed AG |
Jean-Marc Wismer, CEO |
| 11:04-11:12 |
OD-OS |
Winfried Teiwes, CEO |
| 11:12-11:20 |
NeoVista, Inc. |
John Hendrick, President & CEO |
|
|
| 11:20 - 12:00 |
Benefit vs. Risk at the FDA - How does FDA judge and how can companies plan?
Moderator:
Matthew McMahon, PhD Senior Advisor for Transitional Research - National Eye Institute
Panelists:
Mark Abelson, MD, CM, FRCS, Chairman & CSO - Ora, Inc.
Wiley Chambers, MD, Medical Officer - FDA
Malvina Eydelman, MD, Division of Ophthalmic, Neurological, & ENT Devices - FDA
Judy Gordon, DVM Founder & President - ClinReg Consulting Services
Gary Novack, PhD, President - PharmaLogic Development, Inc.
|
|
| 12:00 - 12:30 |
Sector Overview
12:00-12:10
A Public View of the Ophthalmic Sector
Anthony Gibney, Managing Director - Leerink Swann
12:10-12:20
Private Funding and Exit Trends in the Biotech and Medical Device Industries
Jon Norris, Managing Director - SVB Capital
12:20-12:30
Private Funding and Exits trends in Ophthalmology
Ellen Foster Licking, Executive Editor - Elsevier Business Intelligence
|
|
| 12:30 - 2:00 |
Luncheon and “The Road to Success“
Highlighting exceptional contributions to ophthalmic innovation and entrepreneurship
2011 Award Recipient:
Ron M. Kurtz, MD, VP and General Manager - Alcon LenSx, Inc.
Introduction By:
David Guyer, MD, Partner - SV Life Sciences
Interviewed By:
William J. Link, PhD, Managing Director - Versant Ventures |
|
| 2:00 - 3:00 |
Ophthalmic Innovation in the 21st Century
Moderator:
Andy Corley, President - Yelroc Consulting
Panelists:
Richard L. Lindstrom, MD, Founder & Attending Surgeon, Minnesota Eye Consultants
Adjunct Professor Emeritus & University of Minnesota Department of Ophthalmology
Leslie Norwalk, Former Director - CMS
Jeff Shuren, MD, JD, Director, CDRH - FDA
|
|
| 3:00 - 3:45 |
Staged Buyouts - Getting to "Win-Win"
Moderator:
Nick Galakatos, PhD, Managing Director - Clarus Ventures, LLC
Panelists:
David Redlick, Partner and Co-Chair - Life Sciences Group - WilmerHale
Dominik Escher, PhD, Managing Director and VP R&D - ESBATech
Lukas Scheibler, Vice President R&D Alliances - Alcon Laboratories, Inc.
Dean Mitchell, President & CEO - Lux Biosciences, Inc.
Abbie Celniker, Former CEO - Taligen Therapeutics
|
|
| 3:45 - 4:15 |
Afternoon Refreshment and Networking Break |
|
| 4:15 - 4:55 |
Dry AMD - The Next Frontier
Moderator:
David Guyer, MD, Partner - SV Life Sciences
Panelists:
Anthony P. Adamis, MD, Vice President, Global Head of Opthalmology - Genetech
Adjunct Professor of Ophthalmology & Visual Science - University of Illonois
Lecturer, Department of Ophthalmology - Harvard Medical School
Wiley Chambers, MD, Medical Officer - FDA
Scott Cousins, MD, Professor of Ophthalmology - Duke University
Carl Romano, Senior Director - Alcon Laboratories, Inc.
Scott Whitcup, MD, EVP, R&D and Chief Scientific Officer Allergan, Inc.
|
|
| 4:55 - 5:45 |
The Premium Channel - Challenges & Opportunities
Moderator:
William J. Link, PhD, Managing Director - Versant Ventures
Panelists:
Jim Mazzo, President - Abbott Medical Optics Inc. and SVP - Abbott Laboratories
Andy Corley, Senior Advisor - Bausch + Lomb Surgical
Stuart Raetzman, President US and VP, Global Marketing - Alcon Laboratories, Inc.
|
|
| 5:45 - 6:00 |
Summit Wrap Up
Emmett Cunningham, Jr., MD, PhD, MPH, Partner – Clarus Ventures, LLC
Gilbert Kliman, MD, Managing Director – InterWest Partners
William Link, PhD, Managing Director – Versant Ventures
|
|
| 6:00 - 7:30 |
Cocktail Reception
|
|
| 7:30 |
Summit Adjourns |
|
